Quality Management System for Active pharmaceutical

More documents

Recommendations

Info

Quality Management System - integrating GMP into ISOB.5 EngineeringB.5.1The engineering function plays a major role in the application of GMP concerningdesign, installation, maintenance of, and any changes to, buildings, equipment, andutilities. Calibration, qualification of equipment and validation of processes alsoinvolve engineering expertise.B.5.2Engineers should receive adequate training in GMP and its application in APImanufacture.57
Quality Management System - integrating GMP into ISOAnnex C: ValidationPrincipleThe August 1996 edition of the CEFIC/EFPIA Guidelines on Good Manufacturing Practicesfor Active Ingredients Manufacturers defines validation as the action of proving anddocumenting that any procedure, process, equipment, activity or system will, with a highdegree of assurance, lead to expected results.Validation is inherently relevant to many of the chapters of this document, and particularly tochapter 4 (Design and Development Control), chapter 9 (Manufacturing Process Control) andchapter 10 (Inspection and Testing). Because the concept and practice of validation is of suchpredominant importance to the API industry, it is considered in more detail in this Annex.C.1 Identification of need for validationC.1.1While all processes used in the production of API should be well controlled, qualitycritical steps which have a direct impact on the quality of the API, particularly fromthe final intermediate onward, should be validated.C.1.2The development and introduction of new quality critical activities such asmanufacturing processes, equipment, analytical methods, etc. should activate thevalidation process.C.1.3Changes to existing quality critical activities should only be introduced oncevalidation is completed, documented and approved.C.2 Chronological aspects of validationC.2.1Retrospective validation should review and analyse on the basis of historicalevidence in the form of accumulated production, testing, and control data.C.2.2Concurrent validation should generate the necessary evidence during actualimplementation. During this phase, batches of product will be released on the basisof more extensive testing than when the validation programme is fully completed.C.2.3Prospective validation should apply to all relevant new or modified processes, andshould commence during the development stage. It is usually the result of a riskanalysis performed on the proposed new or modified production process.58
Page 2:
Quality Management System - integra
Page 6 and 7:
Quality Management System - integra
Page 8 and 9: Quality Management System - integra
show all

Quality Management System for Active pharmaceutical

Create successful ePaper yourself

Delete template?

Save as template?